德甲官网中文版

  • INNOVATION
  • <tfoot id='Cal7u'></tfoot>

      <legend id='3mQ035'><style id='txwT9I'><dir id='Fmy40BB'><q id='WflfSpK'></q></dir></style></legend>
      <i id='IC14A'><tr id='cEgt'><dt id='mXNS'><q id='nnTaTI'><span id='E2MIwSb'><b id='0ZZVOKn'><form id='iRkc86'><ins id='6dGKag2'></ins><ul id='hRjwSO'></ul><sub id='hdYiCt'></sub></form><legend id='Yxaz6'></legend><bdo id='D20bt'><pre id='gdoSr'><center id='CZIdl9F7'></center></pre></bdo></b><th id='KLTQi'></th></span></q></dt></tr></i><div id='VKalDMjx'><tfoot id='WSjr1w'></tfoot><dl id='uyCrH'><fieldset id='LNKpQ4'></fieldset></dl></div>

          <bdo id='6owsgC'></bdo><ul id='CdjoHF'></ul>

          1. <li id='M9Sg7'><abbr id='UOJ49r'></abbr></li>
          2. INNOVATION
          3. <tfoot id='Cal7u'></tfoot>

              <legend id='3mQ035'><style id='txwT9I'><dir id='Fmy40BB'><q id='WflfSpK'></q></dir></style></legend>
              <i id='IC14A'><tr id='cEgt'><dt id='mXNS'><q id='nnTaTI'><span id='E2MIwSb'><b id='0ZZVOKn'><form id='iRkc86'><ins id='6dGKag2'></ins><ul id='hRjwSO'></ul><sub id='hdYiCt'></sub></form><legend id='Yxaz6'></legend><bdo id='D20bt'><pre id='gdoSr'><center id='CZIdl9F7'></center></pre></bdo></b><th id='KLTQi'></th></span></q></dt></tr></i><div id='VKalDMjx'><tfoot id='WSjr1w'></tfoot><dl id='uyCrH'><fieldset id='LNKpQ4'></fieldset></dl></div>

                  <bdo id='6owsgC'></bdo><ul id='CdjoHF'></ul>

                  1. <li id='M9Sg7'><abbr id='UOJ49r'></abbr></li>
                  2. PRODUCTS
                  3. <tfoot id='Cal7u'></tfoot>

                      <legend id='3mQ035'><style id='txwT9I'><dir id='Fmy40BB'><q id='WflfSpK'></q></dir></style></legend>
                      <i id='IC14A'><tr id='cEgt'><dt id='mXNS'><q id='nnTaTI'><span id='E2MIwSb'><b id='0ZZVOKn'><form id='iRkc86'><ins id='6dGKag2'></ins><ul id='hRjwSO'></ul><sub id='hdYiCt'></sub></form><legend id='Yxaz6'></legend><bdo id='D20bt'><pre id='gdoSr'><center id='CZIdl9F7'></center></pre></bdo></b><th id='KLTQi'></th></span></q></dt></tr></i><div id='VKalDMjx'><tfoot id='WSjr1w'></tfoot><dl id='uyCrH'><fieldset id='LNKpQ4'></fieldset></dl></div>

                          <bdo id='6owsgC'></bdo><ul id='CdjoHF'></ul>

                          1. <li id='M9Sg7'><abbr id='UOJ49r'></abbr></li>
                          2. CAREER
                          3. <tfoot id='Cal7u'></tfoot>

                              <legend id='3mQ035'><style id='txwT9I'><dir id='Fmy40BB'><q id='WflfSpK'></q></dir></style></legend>
                              <i id='IC14A'><tr id='cEgt'><dt id='mXNS'><q id='nnTaTI'><span id='E2MIwSb'><b id='0ZZVOKn'><form id='iRkc86'><ins id='6dGKag2'></ins><ul id='hRjwSO'></ul><sub id='hdYiCt'></sub></form><legend id='Yxaz6'></legend><bdo id='D20bt'><pre id='gdoSr'><center id='CZIdl9F7'></center></pre></bdo></b><th id='KLTQi'></th></span></q></dt></tr></i><div id='VKalDMjx'><tfoot id='WSjr1w'></tfoot><dl id='uyCrH'><fieldset id='LNKpQ4'></fieldset></dl></div>

                                  <bdo id='6owsgC'></bdo><ul id='CdjoHF'></ul>

                                  1. <li id='M9Sg7'><abbr id='UOJ49r'></abbr></li>
                                  2. ACHIEVE SUCCESS TOGETHER
                                  3. <tfoot id='Cal7u'></tfoot>

                                      <legend id='3mQ035'><style id='txwT9I'><dir id='Fmy40BB'><q id='WflfSpK'></q></dir></style></legend>
                                      <i id='IC14A'><tr id='cEgt'><dt id='mXNS'><q id='nnTaTI'><span id='E2MIwSb'><b id='0ZZVOKn'><form id='iRkc86'><ins id='6dGKag2'></ins><ul id='hRjwSO'></ul><sub id='hdYiCt'></sub></form><legend id='Yxaz6'></legend><bdo id='D20bt'><pre id='gdoSr'><center id='CZIdl9F7'></center></pre></bdo></b><th id='KLTQi'></th></span></q></dt></tr></i><div id='VKalDMjx'><tfoot id='WSjr1w'></tfoot><dl id='uyCrH'><fieldset id='LNKpQ4'></fieldset></dl></div>

                                          <bdo id='6owsgC'></bdo><ul id='CdjoHF'></ul>

                                          1. <li id='M9Sg7'><abbr id='UOJ49r'></abbr></li>
                                          2. NEWS
                                          3. <tfoot id='Cal7u'></tfoot>

                                              <legend id='3mQ035'><style id='txwT9I'><dir id='Fmy40BB'><q id='WflfSpK'></q></dir></style></legend>
                                              <i id='IC14A'><tr id='cEgt'><dt id='mXNS'><q id='nnTaTI'><span id='E2MIwSb'><b id='0ZZVOKn'><form id='iRkc86'><ins id='6dGKag2'></ins><ul id='hRjwSO'></ul><sub id='hdYiCt'></sub></form><legend id='Yxaz6'></legend><bdo id='D20bt'><pre id='gdoSr'><center id='CZIdl9F7'></center></pre></bdo></b><th id='KLTQi'></th></span></q></dt></tr></i><div id='VKalDMjx'><tfoot id='WSjr1w'></tfoot><dl id='uyCrH'><fieldset id='LNKpQ4'></fieldset></dl></div>

                                                  <bdo id='6owsgC'></bdo><ul id='CdjoHF'></ul>

                                                  1. <li id='M9Sg7'><abbr id='UOJ49r'></abbr></li>
                                                    Alphalin
                                                    Flunixin Meglumine Injection

                                                     It is the first nonsteroidal analgesic agent in China with anti-inflammatory and antipyretic activity only used for animal.

                                                     
                                                    Main Ingredients

                                                    Flunixin Meglumine

                                                    Advantages
                                                    Antiendotoxin 

                                                    Non-immunosuppressive
                                                    Effectively antipyretic and analgesic
                                                    Enhance antimicrobial efficacy

                                                    Character
                                                    Clear liquid, colorless or light yellow
                                                     
                                                    Pharmacology
                                                    Pharmacodynamics  Flunixin meglumine is a potent inhibitor of the enzyme cyclooxygenase, with anti-inflammatory analgesic antirheumatic and antipyretic activity. The analgesic function is due to blocking the pain impulse conduction via inhibition of peripheral prostaglandins or the synthesis of pain sensitization material or both. The anti-inflammatory effects at peripheral tissue is due to blocking the cyclo-oxygenase pathway, reducing the production of prostaglandins and inhibiting other media producing localized inflammatory reaction. Flunixin meglumine does not affect the gastrointestinal motility of horse and may have the ability to improve hemodynamics of septic shock animals.
                                                     
                                                    Pharmacokinetics   Flunixin meglumine was administered at an actual dose of 2.22mg per kg IM and can be detected after 18h. The plasma terminal half-life was 3-4 hours, the peak concentrations was 2.94μg/ml and the Tmax was 0.4 hours. The apparent volume of distribution is 2.0L/kg, while the bioavailability of single shot neck injection is 87%.
                                                      
                                                    Precautions
                                                    Do not administer other non-steroidal anti-inflammatory drugs (NSAIDs) concurrently or within 24 hours of each other. Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead to toxic effects.
                                                      
                                                    Indications
                                                    Mainly used for fever, inflammatory diseases, muscle pain and soft tissue pain etc., such as sow agalactia syndrome.

                                                    Dosage and Administration
                                                    For use in pigs, the recommended dose rate is 0.04ml/kg bodyweight once by intramuscular or intravenous injection.
                                                      
                                                    Adverse Reaction
                                                    The most common untoward effect for dog is vomit, diarrhea and gastrointestinal ulcers. 
                                                      
                                                    Warning
                                                    Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is the possibility of gastro-intestinal ulceration or bleeding, where there is evidence of a blood dyscrasia or hypersensitivity to the product.
                                                     
                                                    Do not use in dehydrated animals suffering from ileusassociated colic.
                                                     
                                                    Withdrawal Period
                                                    Pigs: 28 Days (tentatively)
                                                      
                                                    Storage
                                                    Store in cool, dry place and keep away from heat and direct sunlight.  
                                                      
                                                    Specification
                                                    100mL: 5g (Flunixin)
                                                     
                                                    Package 
                                                    100mL/bottle, 20 bottles/case.
                                                     

                                                    德甲官网中文版【电子】有限公司